Skip to main content
Log in

Concomitant Myeloproliferative and Lymphoid Neoplasms in Two Patients Positive for JAK2 V617F Mutation. Case Report and Literature Review

  • Case Report
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

Abstract

The coexistence of both myeloproliferative and lymphoproliferative neoplasms in the same patient is an uncommon finding. We report two patients who presented such an association. The first patient was initially diagnosed with essential thrombocythemia, developing a clinical and haematological picture consistent with chronic lymphocytic leukaemia several years afterwards. The second patient was diagnosed concomitantly with polycythaemia vera and chronic lymphocytic leukaemia. Both patients were positive for the JAK2 V617F mutation. In the first patient the chronic lymphocytic leukaemia was asymptomatic, stage A, and did not require any additional treatment, while the second patient presented with generalized large lymphadenopathy (stage B) and chronic lymphocytic leukaemia-related symptoms, requiring chronic lymphocytic leukaemia-directed treatment. It is unclear whether there is a pathogenetic link between the myeloproliferative and lymphoproliferative diseases encountered in these patients, both being probably the result of random mutations occurring in distinct initiating cells. However, given the higher risk of lymphoproliferative neoplasms development in myeloproliferative neoplasms patients reported in larger studies, the genomic instability characteristic to myeloproliferative neoplasms may play a role in subsequent lymphoproliferative neoplasms occurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Jones AV, Kreil S, Zoi K et al (2005) Widespread occurrence of the JAK2 V6l7F mutation in chronic myeloproliferative disorders. Blood 106:2162–2168

    Article  PubMed  CAS  Google Scholar 

  2. Trifa AP, Cucuianu A, Petrov L et al (2010) The G allele of the JAK2 rs10974944 SNP, part of JAK2 46/1 haplotype, is strongly associated with JAK2 V617F-positive myeloproliferative neoplasms. Ann Hematol 89(10):979–983

    Article  PubMed  CAS  Google Scholar 

  3. Shanafelt TD, Byrd JC, Call TG, Zent CS, Kay NE (2006) Narrative review: initial management of newly diagnosed, early-stage chronic lymphocytic leukemia. Ann Intern Med 145:435–447

    Article  PubMed  Google Scholar 

  4. Trifa AP, Cucuianu A, Popp RA (2010) Development of a reliable PCR-RFLP assay for investigation of the JAK2 rs10974944 SNP, which might predispose to the acquisition of somatic mutation JAK2 V617F. Acta Haematol 123(2):84–87

    Article  PubMed  Google Scholar 

  5. Binet JL, Auquier A, Dighiero G et al (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48(1):198–206

    Article  PubMed  CAS  Google Scholar 

  6. Gabrail NY, Martin TW (1998) Coexistence of essential thrombocythemia and chronic lymphocytic leukemia. Acta Haematol 85:31–33

    Article  Google Scholar 

  7. Marcos Sanchez F, Juarez Ucerlay F, Lobato de Blas C, Llanos del Ama ML, Duran Perez-Navarro A (1995) Simultaneous presentation of chronic lymphocytic leukosis and essential thrombocythemia. Ann Med Intern 12(11):566

    CAS  Google Scholar 

  8. Bizzaro N (1998) Chronic lymphocytic leukaemia in a patient with essential thrombocythemia. Clin Lab Haematol 20:377–379

    Article  PubMed  CAS  Google Scholar 

  9. Robak T, Urbańska-Ryś H, Góra-Tybor J et al (2003) Coexistence of chronic lymphocytie leukemia and essential thrombocythemia. Leuk Lymphoma 44:1425–1431

    Article  PubMed  Google Scholar 

  10. Henry L, Carillo S, Jourdan E, Arnaud A, Brun S, Lavabre-Bertrand T (2007) Association of essential thrombocythemia and chronic lymphocytic leukemia: absence of the V617F JAK2 mutation in the lymphoid compartment. Am J Hematol 82:500–501

    Article  PubMed  Google Scholar 

  11. Tabaczewski P, Nadesan S, Lim SH (2009) Zap-70 positive chronic lymphocytic leukemia co-existing with Jak 2 V671F positive essential thrombocythemia: a common defective stem cell? Leuk Res 33(6):854–855

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  12. Kodali S, Chen C, Rathnasabapathy C, Wang JC (2009) JAK2 mutation in a patient with CLL with coexistent myeloproliferative neoplasm (MPN). Leuk Res 33(12):e236–e239

    Article  PubMed  CAS  Google Scholar 

  13. Hussein K, Brakensiek K, Ballmaier M et al (2006) B-CLL developing in a patient with PV is not affected by V617F mutation of the Janus kinase 2. Eur J Haematol 77(6):539–541

    Article  PubMed  CAS  Google Scholar 

  14. Vannucchi AM, Masala G, Antonioli E et al (2009) Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms. Cancer Epidemiol Biomarkers Prev 18(7):2068–2073

    Article  PubMed  CAS  Google Scholar 

  15. Rumi E, Passamonti F, Elena C et al (2011) Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients. Haematologica 96(3):454–458

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This study was partially supported by the project: POSDRU 107/1.5/S/78702.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Adrian P. Trifa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Trifa, A.P., Cucuianu, A., Popp, R.A. et al. Concomitant Myeloproliferative and Lymphoid Neoplasms in Two Patients Positive for JAK2 V617F Mutation. Case Report and Literature Review. Indian J Hematol Blood Transfus 30 (Suppl 1), 120–123 (2014). https://doi.org/10.1007/s12288-013-0281-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-013-0281-0

Keywords

Navigation